Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Non-Current Assets (2021 - 2025)

Historic Non-Current Assets for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to $314.4 million.

  • Krystal Biotech's Non-Current Assets rose 1682.68% to $314.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 2509.99%. This contributed to the annual value of $313.8 million for FY2024, which is 3616.77% up from last year.
  • Krystal Biotech's Non-Current Assets amounted to $314.4 million in Q3 2025, which was up 1682.68% from $297.0 million recorded in Q2 2025.
  • Over the past 5 years, Krystal Biotech's Non-Current Assets peaked at $314.4 million during Q3 2025, and registered a low of $37.2 million during Q1 2021.
  • Moreover, its 5-year median value for Non-Current Assets was $200.0 million (2023), whereas its average is $205.7 million.
  • The largest annual percentage gain for Krystal Biotech's Non-Current Assets in the last 5 years was 38095.29% (2022), contrasted with its biggest fall of 508.46% (2022).
  • Quarter analysis of 5 years shows Krystal Biotech's Non-Current Assets stood at $184.0 million in 2021, then decreased by 5.08% to $174.7 million in 2022, then soared by 31.93% to $230.4 million in 2023, then soared by 36.17% to $313.8 million in 2024, then rose by 0.21% to $314.4 million in 2025.
  • Its Non-Current Assets was $314.4 million in Q3 2025, compared to $297.0 million in Q2 2025 and $307.6 million in Q1 2025.